Table 1.
HantaReg information categories documented.
Category | Subcategory |
---|---|
Epidemiology | Age group at diagnosis, sex, weight, year and place of infection, ethnicity, occupation |
Pre-existing diseases | Malignancy, HIV/AIDS, solid organ transplantation, chronic renal disease, chronic liver disease, chronic cardiovascular disease, chronic pulmonary disease and autoimmune disorder |
Clinical presentation | Signs and symptoms including vital signs at admission, after 24 and 72 h and at the day of discharge, disease course, HFRS, HCPS |
Diagnostics | Virological analyses and imaging procedures for the diagnosis of hantavirus infection, laboratory blood and urine results |
Therapeutic approach | Admission to ICU; antiviral and diuretic treatment approaches (drug, dose, duration, administration and adverse effects), renal replacement therapy (indication, mode of dialysis, duration and adverse effects), mechanical ventilation (duration), ECMO |
Outcome | Outcome of hantavirus diseases, time of hospitalization, readmission to the hospital, long term outcome on kidney function, development of chronic disease after hantavirus disease |
AIDS, acquired immunodeficiency syndrome; ECMO, extracorporeal membrane oxygenation; HCPS, hantavirus cardiopulmonary syndrome; HFRS, haemorrhagic fever with renal syndrome; HIV, human immunodeficiency virus; ICU, intensive care unit.